PEDIATRICS Vol. 98 No. 1 July 1996, pp. 161
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bertotto, A.
Right arrow Articles by Vaccaro, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bertotto, A.
Right arrow Articles by Vaccaro, R.

Mantoux Test in Kawasaki Disease

Alberto Bertotto MD1, Fabrizio Spinozzi MD1, Maurizio Radicioni MD1, and Renato Vaccaro MD1

1 Departments of Pediatrics and Internal Medicine, Perugia University Medical School, Policlinico-Monteluce, 1-06100 Perugia, Italy

Localized erythema at the site of a previous bacillus Calmette-Guérin (BCG) inoculation is a relatively specific and early manifestation of Kawasaki disease (KD),1 and redness and crusting are characteristic features at the site of BCG immunization during the acute phase of the illness.2 With these findings in mind, we evaluated the tuberculin skin test reactivity of children with KD, as determined by a commercially available (Sclavo, Siena, Italy) and intradermally injected (5 TU) purified protein derivative (PPD).